Adhesion failure during storage – inspection finding risk


Published on 02/01/2026

Investigating Adhesion Failures in Transdermal Patches During Storage

Adhesion failure in transdermal patches during storage can pose significant risks to product quality and patient safety. Such failures may lead to ineffective delivery of therapeutic agents, complaints from patients, and potential regulatory scrutiny. This article outlines practical investigative steps to identify the root causes of adhesion failure, addressing signals from the manufacturing floor or laboratory, containment actions, investigation workflows, and corrective and preventive actions (CAPA).

By the end of this article, you will have a structured approach to manage adhesion failures, ensuring compliance with GMP regulatory requirements while enhancing your inspection readiness for audits by FDA, EMA, or MHRA.

Symptoms/Signals on the Floor or in the Lab

Identifying symptoms or signals of adhesion failure is the first step in managing potential product defects. Common indications might include:

  • Physical Observations: Detachment of patches from substrates or backing layers during routine handling or pre-distribution quality checks.
  • Quality Control Reports:
Non-conformance reports related to adhesion properties recorded during testing.
  • Customer Complaints: Increased reports from healthcare providers and patients regarding the efficacy of delivered patches.
  • Deviations in Testing: Out-of-specification (OOS) results for adhesion tests documented in stability assays.
  • Monitoring these signals through routine audits, operator training, and quality control samples will help in swift identification of potential issues. Ensuring comprehensive documentation of these symptoms is critical for subsequent investigation phases.

    Likely Causes

    Adhesion failures due to defects often arise from a combination of factors categorized into six major categories: Materials, Method, Machine, Man, Measurement, and Environment. Understanding each category will expedite your investigation’s efficiency.

    Category Potential Causes
    Materials Incompatible adhesive formulations; quality deterioration of raw materials.
    Method Inappropriate application procedures or protocols; variations in manufacturing conditions.
    Machine Equipment malfunction or improper calibration; cleanliness issues causing adhesion interference.
    Man Insufficient training for operators; human error during production.
    Measurement Incorrect testing methods leading to inaccurate adhesion values; variations in testing environments.
    Environment Improper storage conditions (temperature, humidity); contamination during storage prior to testing.

    Immediate Containment Actions (first 60 minutes)

    Upon identifying adhesion failures, swift containment actions must be implemented to mitigate risks to product quality and regulatory compliance:

    • Isolate Affected Batches: Remove any affected batches from circulation immediately to prevent distribution.
    • Notify Quality Assurance: Engage QA personnel to initiate formal deviation documentation per the organization’s standard operating procedures (SOPs).
    • Implement CAPA Procedures: Initiate CAPA processes to start identifying potential root causes.
    • Document Findings: Record all observations, symptoms, and actions taken within the first hour.

    By isolating affected batches and engaging QA functions, you lessen the risk of sending compromised products to market and maintain compliance with regulatory standards.

    Investigation Workflow (data to collect + how to interpret)

    The investigation workflow begins post-containment. Key components include data collection, analysis, and interpretation. Suggested steps are:

    1. Gather Data: Collect all relevant information, including batch records, quality control reports, environmental monitoring data, and operator logs. This may involve retrieving stability data, material specifications, and production process documentation.
    2. Analyze Deviations: Cross-reference documented symptoms against batch records to identify any correlations or patterns. Trace back through the production timeline using both computer and paper records.
    3. Identify Trends: Use statistical process control (SPC) tools to assess any changes in production that may correlate with failure reports. Pay special attention to any critical control points in manufacturing.
    4. Evaluate System Effectiveness: Assess control systems in place—both technical and procedural—to determine if they functioned properly through the production and storage phases.

    Effective interpretation of the collected data can illuminate potential problem areas, which is vital for proceeding with a robust root cause analysis.

    Root Cause Tools (5-Why, Fishbone, Fault Tree) and When to Use Which

    Selecting the appropriate analytical tool for root cause analysis is essential for efficient problem resolution. The following tools are commonly applied in deviation investigations:

    5-Why Analysis

    The 5-Why method involves sequentially asking “why” to drill down from the symptoms to the root cause. This approach is particularly useful for straightforward problems and can be applied in group settings to stimulate discussion.

    Fishbone Diagram

    Also known as the Ishikawa diagram, this tool visually categorizes potential causes of problems. It is beneficial for multifactorial issues like adhesion failures, allowing teams to brainstorm causes associated with each category (Materials, Method, Machine, Man, Measurement, Environment).

    Fault Tree Analysis (FTA)

    This deductive tool focuses on identifying paths leading to a failure. It is more complex and is best used when specific events or mechanisms need to be systematically uncovered through a top-down approach. FTA is useful for understanding interactions between various components of a system.

    Understand your team’s strengths and the complexity of the issue when choosing between these tools. A combination may sometimes yield the best results.

    CAPA Strategy (correction, corrective action, preventive action)

    CAPA is integral to the resolution of manufacturing defects, ensuring adherence to FDA, EMA, and MHRA requirements. Here’s how to establish a thorough CAPA strategy:

    1. Correction: Define immediate corrective measures that target the issue observed. This may involve re-evaluating production methodologies or retraining staff on operating procedures.
    2. Corrective Action: Develop and implement long-term solutions based on root cause findings. For example, if the root cause is determined to be a defective adhesive material, sources of supply may need reassessment or validation.
    3. Preventive Action: Design strategies to prevent recurrence. This may involve revising standard operating procedures (SOPs), enhancing training programs, or strengthening supplier quality agreements.

    Proper documentation of each step is crucial for regulatory submissions and future reference during inspections.

    Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)

    Your control strategy must ensure that processes remain within defined limits to prevent recurrence of deviations. Consider the following for an effective control strategy:

    Related Reads

    • Statistical Process Control (SPC): Implement real-time monitoring of key parameters during manufacturing. Use control charts to visualize trends and detect anomalies quickly.
    • Sampling Plans: Develop targeted sampling strategies for finished products and raw materials to continuously assess adhesion properties.
    • Automated Alarms: Utilize machine alarms and alerts for critical manufacturing steps to prevent deviations before they occur.
    • Verification Procedures: Regularly verify that all changes made through CAPA are effective and that control measures are functioning as intended.

    Document control strategy adjustments, providing transparency for audits and inspections while reinforcing a culture of compliance.

    Validation / Re-qualification / Change Control impact (when needed)

    Any adjustments stemming from investigations, CAPA, or changing materials will necessitate a formal evaluation of validation and change control processes. Key areas to consider include:

    • Validation: Determine if the modifications made to processes or materials impact the current validation status. A full revalidation may be required based on the scale of the change.
    • Re-qualification: Assess whether equipment used must undergo re-qualification due to procedural changes affecting its operation.
    • Change Control: Follow strict change control regulations to identify, document, and assess any procedural or material changes initiated as part of the corrective actions.

    Collaboration with the validation team ensures that modifications do not compromise the integrity of the product or process.

    Inspection Readiness: What Evidence to Show (records, logs, batch docs, deviations)

    Maintaining thorough records is crucial for compliance and inspection readiness. During an FDA, EMA, or MHRA audit, ensure the following documentation is readily available:

    • Deviation Reports: Comprehensive documentation of the deviation’s timeline, actions taken, and results of investigations.
    • Batch Records: Accurate and complete batch manufacturing and control records provide a traceable history of each lot produced.
    • Quality Control Logs: Retain all relevant QC testing data tying back to the manufacturing parameters affecting adhesion.
    • Training Records: Ensure appropriate training documentation is available to exhibit adherence to procedures by operators.

    Inspection readiness hinges on the ability to provide evidence of a structured and compliant approach to quality management.

    FAQs

    What are the common symptoms of adhesion failure in transdermal patches?

    Common symptoms include detachment from substrates, increased complaints from users, and OOS results during quality testing.

    How do I isolate affected batches?

    Immediately remove affected batches from circulation to prevent distribution and inform quality assurance of the issue.

    What is a deviation report?

    A deviation report documents any non-conformance observed, detailing the circumstances, immediate actions, and the outcome of investigations.

    What tools can be used for root cause analysis?

    Common tools include the 5-Why analysis, Fishbone diagrams, and Fault Tree Analysis (FTA).

    What is a CAPA strategy?

    A CAPA strategy outlines steps taken to correct and prevent recurrence of issues, including immediate corrections, long-term corrective actions, and preventive measures.

    What are the consequences of not addressing adhesion failures?

    Consequences may include regulatory action, financial loss due to product recalls, and reputational damage.

    How often should control strategies be updated?

    Control strategies should be reviewed and updated regularly, particularly following a change or whenever data indicates a need for improvement.

    What is the importance of documentation in investigations?

    Documentation provides a transparent record of decision-making, facilitates communication between teams, and is essential for regulatory compliance.

    What regulatory bodies should be considered when developing quality processes?

    Consider the FDA in the US, EMA in Europe, and MHRA in the UK for compliance with their guidelines and regulations during manufacturing.

    When should a re-validation occur?

    Re-validation is necessary when significant changes to the process or the equipment occur, affecting product quality or safety.

    How can I ensure inspection readiness?

    Maintain accurate records, follow documented procedures, train staff thoroughly, and review processes regularly to ensure compliance with regulations.

    What is SPC and its significance?

    Statistical Process Control (SPC) is a method of quality control using statistical methods to monitor and control a process, crucial for maintaining product quality and compliance.

    Pharma Tip:  Dose delivery inconsistency during storage – process vs material root cause